{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"HealthTech Remedy","title":"How Viz.ai's AI Platform Is Fixing Clinical Workflows with CEO & Founder Chris Mansi","html":"","width":"100%","height":180,"duration":2700,"description":"In modern medicine, a patient's outcome often depends less on the skill of their doctor and more on the speed and efficiency of the hospital system itself. When workflows break down, critical time is lost, and lives are put at risk. This episode provides a comprehensive analysis of the Viz.ai AI healthcare platform, a company at the forefront of solving this problem by using artificial intelligence to detect disease earlier and coordinate care faster. We are joined by Viz.ai's co-founder and CEO, Chris Mansi, a former neurosurgeon who saw firsthand how fragmented communication could lead to devastating consequences and set out to build a solution.How can a simple software platform save lives in cases of stroke, pulmonary embolism, and cancer? In this deep dive, we explore the rise of Viz.ai, from its initial breakthrough in AI for stroke detection to its current status as a unicorn company installed in over 1,800 hospitals. We dissect how their technology optimizes AI in clinical workflows, not just by flagging critical findings on medical images, but by mobilizing entire care teams in real-time. The discussion covers the \"time is brain\" philosophy that drives the company’s mission and the powerful real-world evidence, backed by over 100 publications, demonstrating how this approach reduces treatment delays and improves patient outcomes. This has allowed Viz.ai to expand far beyond stroke to tackle aortic disease, hypertrophic cardiomyopathy, cancer, and more, proving the power of a unified platform.We also analyze the company's evolving business strategy, particularly the crucial role of Viz.ai pharma partnerships. These collaborations with companies like BMS, Sanofi, and Medtronic are not just a revenue driver; they are essential for expanding the platform's reach into chronic diseases and ensuring that life-saving treatments get to the right patients. The conversation then shifts to the incredible Chris Mansi founder story, as the CEO himself recounts the...","thumbnail_url":"https://img.transistorcdn.com/Al9s4QJpRCg2VJ2YaV_fo3tDCayXbUO7NTDbnFeSAUQ/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mNTVk/OTAwMzQxYWFiZmYy/ZWFlNzFmN2RmOTcx/MDMwNy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}